PeproMene Bio

PeproMene Bio, Inc. is a clinical-stage biotechnology company. We are dedicated to developing new therapies for the treatment of cancer and immune diseases. Our BAFFR CAR-T therapeutic program is based on a novel antibody targeting B-cell activating factor receptor (BAFF-R) discovered by Dr. Larry Kwak’s team at MD Anderson Cancer Center in Houston, Texas, and City of Hope National Medical Center in Duarte, California.